Posted: JAN 09, 2008

CSMG Technologies Announces Four New Patents for Its Subsidiary Live Tissue Connect, Inc.

Corpus Christi, TX, January 9, 2008 -- CSMG Technologies, Inc., (OTCBB: CTUM - News) a technology management company, announced that its subsidiary, Live Tissue Connect ("LTC"), has filed four new duct and vessel sealing instrument patents.

Don Robbins, President and CEO of CSMG Technologies, said, “We are pleased that we are able to continuously expand our patent portfolio, adding new surgery specific instruments designed for use with the LTC electrosurgery generator. We believe the LTC technology, along with the underlying intellectual property, allows us the opportunity to make significant advances in the worldwide surgery markets. Having received the CE Mark approval on the electrosurgery generator and with commercial manufacturing of instruments and generator in-process, we hope to enter the European markets toward the end of this quarter or early next quarter.”

LTC’s Frank D’Amelio added, “These patent applications are related to our to-be-released new line of disposable bipolar sealing hemostats. Expanding our IP portfolio is a priority for the LTC management team in 2008. These four applications are a great start for our intellectual property pipeline. The concepts described and the claims within these applications were possible as a result of what we believe to be excellent and unique designs coming out of our design house, ViR Engineering.".

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 44 patents and patent applications in the U.S., Australia, Canada, European Union, Ukraine and other countries.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.

Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

CONTACT:

CSMG Technologies, Inc.
Donald S. Robbins, President and CEO
361-887-7546
or
K. Bruce Jones, 770-955-0409
or
ROI Group Associates, Inc.
Michael Dodge, 212-495-0744
mdodge@roiny.com